DrFecz_ (@DFecz) header
DrFecz_ (@DFecz) profile picture

DrFecz_

@DFecz

General thoracic surgery. Tweets are mine alone.

Joined October 2019
  • Tweets308
  • Following0
  • Followers93
26Media
Photo by DrFecz_ (@DFecz)Photo by DrFecz_ (@DFecz)Photo by DrFecz_ (@DFecz)Photo by DrFecz_ (@DFecz)Photo by DrFecz_ (@DFecz)Photo by DrFecz_ (@DFecz)Photo by DrFecz_ (@DFecz)Photo by DrFecz_ (@DFecz)Photo by DrFecz_ (@DFecz)Photo by DrFecz_ (@DFecz)
Replying to @BrendonStilesMD @DrewMoghanaki @ellakaz @DouglasEWood1 @AshleyEProsper @pfccdirector @findlungcancer @arbmckee @LeciaSequist @F_Fintelmann_MD @QuadShotNews
Absolutely agreed. Very misleading. We have published from the @LaheyHospital lung cancer screening program a 0.95% invasive procedure (Dx or Tx) rate in patients without cancer with 0.36% grade III or higher complication rate. Lung Cancer Screening is SAFE!
Image from Elliot Servais, MD, FACS (@ElliotServaisMD)
4
1
5
1,017
A new report once again focuses on the "complications" of lung cancer screening. In total, they found the rate of major complications for people WITHOUT lung cancer = 0.07%. So, why didn't the authors highlight this statistic in the conclusion? 1/🧵 acpjournals.org/doi/epdf/10.…
Image from Drew Moghanaki (@DrewMoghanaki)
4
7
1
30
4,726
Replying to @DrewMoghanaki @ellakaz @DouglasEWood1 @AshleyEProsper @pfccdirector @findlungcancer @arbmckee @LeciaSequist @F_Fintelmann_MD @QuadShotNews
Agree. It is incredibly misleading to include complications related to the treatment of cancer as “screen related complications”. sciencedirect.com/science/ar…
3
6
14
1,940
In honor of the new residents joining the field… a list that still comes in handy. @ericpaulimd
Image from Salvatore Docimo (@Dr_Sal_Docimo)
8
41
3
157
23,570
#juniorradres and all those starting to see chest x-rays 🫁☢️ Here an anatomical guide to get you started! This is a key study in thoracic imaging, often a little overlooked by our generation. Practice makes perfect🤓... Let's get started! 🧵👇🏻 #radiology #radtwitter #FOAMrad
Image from Dra. Cecilia Ferrario (@draceciferrario)
Image from Dra. Cecilia Ferrario (@draceciferrario)
26
605
8
2,186
268,998
IYKYK
Image from Isaiah Turnbull (@isaiah_turnbull)
6
3
11
2,206
We should banish this #stigma with extreme prejudice. Many with #lungcancer have never smoked. But even those who may have smoked don’t deserve to have this horrible #cancer …& they are also no less deserving of our compassion & best efforts to treat them @CancerCareMB #lcsm
Lung Cancer Canada (@LungCancer_Can) profile pictureLung Cancer Canada@LungCancer_Can25 Jun 2023
15%-20% of lung cancer patients have never smoked. So why do we assume that lung cancer is a smoker's disease? buff.ly/3A1ys5p
Image from Lung Cancer Canada (@LungCancer_Can)
2
12
41
8,477
I have a serious recommendation to decrease burnout: portable EPIC training. I am now completing my 7th round of EPIC training. I will not be accepting any comments at this time about how "EPIC is configured differently at each hospital, so you need this." No.
3
2
33
4,999
Residents are telling me they're still being taught old billing rules. Reminder, since Jan 1, 2023: 🔶 HPI has no strict billing requirements. It simply needs to exist 🔶 Same for physical exam 🔶 ROS is no longer required 🔶 PMH, FH, SH are no longer required Also a reminder:
50
210
29
1,373
532,850
Retrospective report @ClinicalLung from the VA system showing better outcomes with surgery than CRT for pts with stage I #SCLC. But major of selection bias to even consider surgery. And need to know how many recurred shortly after surgery and went to CRT? clinical-lung-cancer.com/art…
1
8
17
3,349
Excited to share our recent @SwantonLab @NickyMcGranahan & @MariamJHanjani lab work on the genomic evolution of non-small cell lung cancer metastases in #TRACERx, out @Nature nature.com/articles/s41586-0… A quick thread [1/13]
The evolution of non-small cell lung cancer metastases in TRACERx

The evolution of non-small cell lung cancer metastases in TRACERx

Nature - A longitudinal evolutionary analysis of 126 lung cancer patients with metastatic disease reveals the timing of metastatic divergence, modes of dissemination and the genomic events subject...

nature.com
5
137
10
398
76,965
Atrial Fibrillation Occurring During Acute Hospitalization: A Scientific Statement From the American Heart Association: @CircAHA AHA Statement from out council: @AHA_AcuteCVCare Here is a summary 👇👇👇
Image from Abdulla A. Damluji, MD, PhD (@DrDamluji)
8
163
7
473
102,657
Survival benefit in ADAURA: adjuvant osimertinib for resected #EGFR NSCLC hits secondary endpoint of overall survival. For those not convinced by the profound DFS benefit (HR 0.23 in stage II/IIIA), we now have OS data. @FordePatrick @DrSteveMartin astrazeneca.com/media-centre…

Tagrisso demonstrated strong overall survival benefit in the ADAURA Phase III trial for adjuvant...

astrazeneca.com
7
55
8
146
37,971
Replying to @SAGES_Updates
I give them all my patients - “just in case you forget who talked to you!”
1
1
3
223
We don't normally do political tweets but we will make an exception for presidential mullets. Please read the thread. It's worth it.
Cam Heartless (@camharless) profile pictureCam Heartless
@camharless1 Mar 2023
every american president, but they're all cool and they all sport a mullet 46. Joe Biden
Image from Cam Heartless (@camharless)
3
4
20
12,023
Looks like we have another SoC option cooking for resectable lung cancer patients! #LCSM @IASCL @ASCO @myESMO @STS_CTsurgery @AATSHQ @ThoracicsCanada merck.com/news/merck-announc…
Merck Announces Phase 3 KEYNOTE-671 Trial Met Primary Endpoint of Event-Free Survival (EFS) in...

Merck Announces Phase 3 KEYNOTE-671 Trial Met Primary Endpoint of Event-Free Survival (EFS) in...

In pivotal study, KEYTRUDA® (pembrolizumab) in combination with chemotherapy before surgery and continuing as a single agent after surgery showed a statistically significant improvement in EFS versus...

merck.com
4
14
3
57
18,780
Patient presenting with vomiting and chest pain. What’s the diagnosis?
Image from Keith Siau (@drkeithsiau)
89
213
34
1,757
553,016
Replying to @DFecz @tssmn @CWISociety @abribriesco43 @BrianMitzman @ElliotServaisMD @hari_keshava @biniamkidaneMD
Also current running trial comparing cryo to serratus block to intercostal with MIE
3
1
8
591
Prediction of distant metastases after SBRT for early stage NSCLC - Age and ECOG PS are driving the risk, together with prior lung cancer (independent of current disease) 👉 limited predictive power of tumor specific parameters ❓ therapeutic implications jto.org/article/S1556-0864(2…
Prediction of Distant Metastases After Stereotactic Body Radiation Therapy for Early Stage NSCLC:...

Prediction of Distant Metastases After Stereotactic Body Radiation Therapy for Early Stage NSCLC:...

Distant metastases (DMs) are the primary driver of mortality for patients with early stage NSCLC receiving stereotactic body radiation therapy (SBRT), yet patient-level risk is difficult to predict....

jto.org
3
7
1
33
5,577
HAPPY NEW YEAR!! It’s that time…THORACIC THURSDAY!! Let’s do it! 1) What procedure is pictured below? 2) What structure is the red arrow pointing to? 3) what structure is the green arrow pointing to? #thoracicthursday #surged #MedEd – at Long Beach, CA
Image from Hari B. Keshava (@hari_keshava)
9
9
4
42
23,363
Load more